DAX-0,30 % EUR/USD+0,19 % Gold+0,62 % Öl (Brent)-1,25 %

Mit Pharmaust einen Vervielfacher entdeckt! Insiderkäufe! (Seite 46)


ISIN: AU000000PAA1 | WKN: A0DNJ3
0,0000
CHF
BX Swiss
0,00 %
0,0000 CHF

Begriffe und/oder Benutzer

 

lol

ich hoffe ich sehe meine besch.... 0,06 / aktie wieder habe von dem mist noch viel zu viel im depot

oder vlt. nachkaufen um den kurs zu senken ?
Geschäfte laufen etwas besser

Appendix 4D Half-Year Report for the period ended 31 December 2010 Results for announcement to the Market Financial Performance Pharmaust Limited - Consolidated Half-year ended Half-year ended 31 Dec 2010 31 Dec 2009 815 958 (410) (410) (304) (304) (AUD 000’) Revenue Movement % -15% +35% +35% (Loss) before tax attributable to members (Loss) after tax attributable to members Review of Operations Refer to Directors’ Report included in the attached half-year financial report. Dividends No Dividends were paid or declared for payment during the half year period under review. Earnings Per Share Half-year ended 31 Dec 2010 (Loss) per share (Basic & Diluted) Net Tangible Asset Backing Half year ended 31 Dec 2010 Net tangible asset backing Entities Acquired and Disposed During the Period No entities were acquired or disposed of during the period.

Compliance Statement The report is based on financial statements reviewed by the auditor, a copy of which is attached. Signed in accordance with a resolution of Directors On behalf of the Directors 2.04 cents Half year ended 31 Dec 2009 2.20 cents (0.16) cents Half-year ended 31 Dec 2009 (0.12) cents Bryant Mclarty Director Signed at Perth this 28th day of February 2011 PHARMAUST LIMITED ABN 35 094 006 023 AND ITS CONTROLLED ENTITIES Interim Financial Report for the half-year ended 31 December 2010 C O N T E N T S Directors' Report Condensed Statement of Comprehensive Income Condensed Statement of Financial Position Condensed Statement of Changes in Equity Condensed Statement of Cash Flows Notes to the Financial Statements Directors' Declaration Independent Auditor’s Review Report Auditor’s Independence Declaration 1 PHARMAUST LIMITED DIRECTORS’ REPORT The directors of PharmAust Limited submit the financial report of the consolidated entity for the half-year ended 31 December 2010. DIRECTORS The names of the directors who held office during or since the end of the half-year are: Bryant McLarty Henry Gulev Sam Wright RESULTS The operating loss for the Company for the half-year ended 31 December 2010 was $410,142 (2009: loss of $304,008).

REVIEW OF OPERATIONS EPICHEM – 100% OWNED SUBSIDIARY WA EXPORTER OF THE YEAR AWARD WINNER Epichem continues to see sustained growth in sales of its range of pharmaceutical standards. Sales for these standards during the first half of the 2011 financial year were 46% up on the same period in the previous year. Most of these sales were for the export market despite the high Australian dollar.
Letzter Beitrag 2011? Habe mir mal die Firmenhomepage und die Bilanz angeschaut. 3 Millionen Umsatz 2017, Bilanz bei 8 Millionen.. die Aktie hat doch sicher noch viel Spielraum nach oben? Oder kann mir einer erklären wieso hier seit 7 Jahren tote Hose im Forum ist?
Antwort auf Beitrag Nr.: 57.545.793 von Richyyyyy am 15.04.18 09:47:40
tote Hose
Kam heute von Consors reingeflattert. Mal wieder eine KE: https://www.asx.com.au/asxpdf/20190219/pdf/442qp4w24q8wcv.pdf
4Wer sind die paar "overseas investors" außer mir?
 Durchsuchen


Beitrag zu dieser Diskussion schreiben